Healthcare privacy and regulatory compliance
The company handles sensitive medical data and must meet privacy and de-identification requirements.
- Scope
- Data collection, curation, and licensing workflows
- Materiality
- high
OneMedNet Corp
OneMedNet Corp is a U.S.-based commercial research services company focused on collecting, curating, and delivering medical imaging and related clinical data for research and analytics use. The company operates as a data-enabled services business serving healthcare, life sciences, and other research-oriented customers that need access to de-identified real-world medical data.
−706,5 %
−37,0 %
−206,1 %
+111,4 %
0.43
0.43
| % | |
|---|---|
| Medical imaging data services | 45% Collection, organization, and delivery of imaging data for research and analytics use. |
| Clinical data curation | 30% De-identification and structuring of clinical records and related metadata. |
| Data licensing | 15% Licensing curated datasets to customers for research, model development, and analysis. |
| Research support services | 10% Project support, data preparation, and related services for research workflows. |
OneMedNet’s customers are typically organizations that need high-quality medical data for research, analytics, and...
- Life sciences companiesprimary
Buy curated medical data and research support for evidence generation and development programs.
- Healthcare technology companiesprimary
Use de-identified imaging and clinical data to train, validate, and commercialize analytics tools.
- Research institutionssecondary
Purchase or access datasets for academic, translational, and clinical research projects.
- Healthcare providers and networkssecondary
May contribute data or engage for research-oriented data services and collaborations.
OneMedNet is headquartered in the United States and its business is centered on U.S. healthcare data and research...
- •Headquartered in the United States
- •Primary market is U.S. healthcare and research data
- •Operations depend on access to domestic clinical data sources
- •Regulatory and privacy rules shape where data can be collected and used
The company’s strategy is to expand the utility of its medical data platform by increasing the volume, quality, and...
01
Grow the curated data asset basemedium-term
More and better data increases the platform’s value to research customers.
02
Deepen customer adoption in research marketsmedium-term
Repeat usage and broader customer penetration support commercialization.
03
Maintain compliance and data governanceshort-term
Healthcare data businesses depend on privacy, consent, and regulatory trust.
The business depends on access to regulated healthcare data, so privacy, consent, and data-governance failures could...
Data supply concentration and access risk
The platform depends on continued access to clinical data sources and contributors.
- Scope
- Provider relationships and data ingestion
- Materiality
- high
Commercial adoption risk
Customers must see enough value in the datasets to renew or expand usage.
- Scope
- Life sciences and healthcare analytics demand
- Materiality
- medium
Competition and substitution
Other data vendors or internal customer data assets can reduce demand for the company’s offerings.
- Scope
- Research data licensing market
- Materiality
- medium
Revenue recognition
Can shift revenue between periods and affect comparability
Contract assets and receivables
Affects working capital and credit-loss estimates
Intangible asset and software impairment
Can create non-cash charges if expected cash flows weaken
: 29.4.2026